Premier Perspectives The blog for insider insights in clinical development Clinical Research: Phase 1 - Phase 4 5 Key Takeaways: Insights on Alternative Designs to the Traditional 3+3 Design in Phase 1 Dose Escalation Studies By Andreas Schreiner April 8, 2021 Featured Posts Consulting Parkinson’s: Why Has Disease Modification Failed — and What Now? By Andreas Schreiner December 19, 2018 Clinical ResearchPhase 1 - Phase 4 Finding the Path to Disease Modification in Parkinson’s Disease By Andreas Schreiner November 29, 2018 1 ×
